Hutchmed (China)
HCM
Enerpac Tool
EPAC
Ermenegildo Zegna NV
ZGN
Lantheus
LNTH
eBay
EBAY
US Stock MarketDetailed Quotes
FULC Fulcrum Therapeutics
- 3.700
- 0.0000.00%
Close Feb 25 16:00 ET
- 3.700
- 0.0000.00%
Post 20:01 ET
199.72MMarket Cap-23.13P/E (TTM)
3.800High3.360Low444.58KVolume3.580Open3.700Pre Close1.64MTurnover1.68%Turnover RatioLossP/E (Static)53.98MShares13.70052wk High0.82P/B98.06MFloat Cap2.86052wk Low--Dividend TTM26.50MShs Float33.098Historical High--Div YieldTTM11.89%Amplitude2.250Historical Low3.689Avg Price1Lot Size
Fulcrum Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 97.56%-2.22M | 27.62%-16.76M | 16.74%-19.07M | 383.37%58.9M | -4.84%-25.28M | 6.27%-90.97M | -17.58%-23.16M | 17.85%-22.91M | 24.05%-20.79M | -9.09%-24.12M |
| Net income from continuing operations | 90.01%-9.73M | 33.07%-16.57M | 9.66%-21.7M | 332.98%55.41M | -8.44%-26.87M | 11.41%-97.34M | 5.28%-24.76M | -1.18%-24.02M | 30.19%-23.78M | 4.43%-24.78M |
| Depreciation and amortization | -26.66%1.59M | -27.36%369K | -30.51%369K | -33.69%376K | -15.37%479K | -10.02%2.17M | -14.04%508K | -13.09%531K | -16.12%567K | 5.60%566K |
| Change In working capital | 7.91%-4.25M | -103.10%-2.09M | 73.92%-410K | -112.31%-96K | 40.93%-1.65M | -49.10%-4.61M | -132.43%-1.03M | 80.88%-1.57M | -72.74%780K | -205.25%-2.79M |
| -Change in receivables | -406.17%-1.56M | 3,527.91%1.56M | -1,840.79%-1.32M | -318.85%-2.33M | 313.08%537K | -109.04%-308K | -92.51%43K | -74.41%76K | -86.91%-557K | -95.41%130K |
| -Change in prepaid assets | -27.33%-1.37M | 66.72%-207K | -250.29%-2.42M | -39.40%463K | 253.83%803K | -530.59%-1.07M | -181.20%-622K | 27.99%-692K | 1,176.06%764K | -643.75%-522K |
| -Change in payables and accrued expense | -56.44%-2.63M | -3,727.17%-3.34M | 369.48%1.6M | 107.17%1.94M | -33.63%-2.82M | -170.21%-1.68M | -96.27%92K | 91.53%-593K | -83.92%934K | -11.81%-2.11M |
| -Change in other current assets | 2,028.72%2M | 414.29%66K | 38,160.00%1.91M | -102.78%-1K | -68.92%23K | 106.02%94K | -250.00%-21K | -28.57%5K | 102.79%36K | 127.01%74K |
| -Change in other working capital | 57.55%-700K | 66.35%-176K | 52.72%-174K | 59.70%-160K | 47.37%-190K | 60.26%-1.65M | 15.65%-523K | 34.05%-368K | 69.18%-397K | 78.55%-361K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 97.56%-2.22M | 27.62%-16.76M | 16.74%-19.07M | 383.37%58.9M | -4.84%-25.28M | 6.27%-90.97M | -17.58%-23.16M | 17.85%-22.91M | 24.05%-20.79M | -9.09%-24.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 187.84%32.23M | -87.69%2.26M | -77.13%4.35M | -162.93%-12.51M | 140.59%38.13M | -395.59%-36.69M | 150.48%18.35M | 934.58%19.02M | -36.69%19.88M | -577.85%-93.94M |
| Net PPE purchase and sale | 45.28%-278K | -200.00%-231K | 70.77%-19K | --0 | 83.63%-28K | 74.12%-508K | 33.62%-77K | 77.03%-65K | 85.20%-195K | 30.49%-171K |
| Net investment purchase and sale | 189.84%32.51M | -86.48%2.49M | -77.11%4.37M | -162.32%-12.51M | 140.69%38.16M | -351.70%-36.18M | 150.85%18.43M | 1,056.16%19.09M | -38.65%20.07M | -571.09%-93.77M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 187.84%32.23M | -87.69%2.26M | -77.13%4.35M | -162.93%-12.51M | 140.59%38.13M | -395.59%-36.69M | 150.48%18.35M | 934.58%19.02M | -36.69%19.88M | -577.85%-93.94M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -97.68%2.75M | -71.08%83K | 635K | 165.49%377K | -98.60%1.65M | 40.08%118.12M | 31.65%287K | 0 | -94.95%142K | 33,719.83%117.69M |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | 45.22%117.35M | --0 | --0 | --0 | --117.35M |
| Proceeds from stock option exercised by employees | 253.41%2.75M | -71.08%83K | --635K | 165.49%377K | 374.43%1.65M | -77.92%777K | 7.49%287K | --0 | -94.95%142K | 0.00%348K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -97.68%2.75M | -71.08%83K | --635K | 165.49%377K | -98.60%1.65M | 40.08%118.12M | 31.65%287K | --0 | -94.95%142K | 33,719.83%117.69M |
| Net cash flow | ||||||||||
| Beginning cash position | -26.35%26.66M | 136.85%73.83M | 150.78%87.92M | 14.86%41.15M | -26.35%26.66M | -0.86%36.19M | -66.13%31.17M | -15.00%35.06M | 4.13%35.83M | -0.86%36.19M |
| Current changes in cash | 443.56%32.76M | -219.19%-14.42M | -262.51%-14.09M | 6,189.58%46.77M | 4,082.14%14.5M | -2,936.62%-9.54M | 91.91%-4.52M | -107.65%-3.89M | -111.23%-768K | 82.66%-364K |
| End cash Position | 122.90%59.41M | 122.90%59.41M | 136.85%73.83M | 150.78%87.92M | 14.86%41.15M | -26.35%26.66M | -26.35%26.66M | -66.13%31.17M | -15.00%35.06M | 4.13%35.83M |
| Free cash flow | 97.27%-2.5M | 26.87%-16.99M | 16.89%-19.09M | 380.74%58.9M | -4.22%-25.31M | 7.62%-91.47M | -17.28%-23.24M | 18.44%-22.97M | 26.86%-20.98M | -8.66%-24.29M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |